May 10, 2022 Cellectar Reports Financial Results for First Quarter 2022 and Provides a Corporate Update Learn More
Apr 26, 2022 Cellectar Biosciences Announces Positive DMC Review of Pivotal Trial of Iopofosine in Waldenstrom’s Macroglobulinemia Learn More